Olga Mulas

722 total citations
35 papers, 190 citations indexed

About

Olga Mulas is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Olga Mulas has authored 35 papers receiving a total of 190 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 15 papers in Genetics and 7 papers in Oncology. Recurrent topics in Olga Mulas's work include Chronic Myeloid Leukemia Treatments (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Myeloid Leukemia Research (6 papers). Olga Mulas is often cited by papers focused on Chronic Myeloid Leukemia Treatments (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Acute Myeloid Leukemia Research (6 papers). Olga Mulas collaborates with scholars based in Italy, Austria and Germany. Olga Mulas's co-authors include Giovanni Caocci, Giorgio La Nasa, Marianna Greco, Carlo Carcassi, Roberto Littera, Elisabetta Abruzzese, Alessandro Nanni Costa, Sara Lai, Bruno Martino and Sara Galimberti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Olga Mulas

29 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Mulas Italy 7 105 77 52 48 36 35 190
Laura Fogliatto Brazil 9 92 0.9× 132 1.7× 61 1.2× 52 1.1× 29 0.8× 32 218
Mariarita Sciumé Italy 9 94 0.9× 64 0.8× 40 0.8× 58 1.2× 37 1.0× 26 214
Vincenzo Federico Italy 10 152 1.4× 80 1.0× 59 1.1× 68 1.4× 22 0.6× 26 247
Adriano Salaroli Italy 11 182 1.7× 130 1.7× 63 1.2× 46 1.0× 26 0.7× 29 251
Anna Lübking Sweden 9 156 1.5× 109 1.4× 65 1.3× 55 1.1× 66 1.8× 14 236
Christos Demosthenous Greece 8 77 0.7× 64 0.8× 47 0.9× 61 1.3× 12 0.3× 19 202
Shinichiro Machida Japan 8 151 1.4× 60 0.8× 53 1.0× 74 1.5× 30 0.8× 39 258
Alessandra Cupri Italy 11 214 2.0× 88 1.1× 50 1.0× 76 1.6× 33 0.9× 27 313
Kristina Schilling Germany 7 228 2.2× 109 1.4× 47 0.9× 35 0.7× 20 0.6× 14 267
Caterina Stefanizzi Italy 10 177 1.7× 114 1.5× 39 0.8× 62 1.3× 45 1.3× 25 237

Countries citing papers authored by Olga Mulas

Since Specialization
Citations

This map shows the geographic impact of Olga Mulas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Mulas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Mulas more than expected).

Fields of papers citing papers by Olga Mulas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Mulas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Mulas. The network helps show where Olga Mulas may publish in the future.

Co-authorship network of co-authors of Olga Mulas

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Mulas. A scholar is included among the top collaborators of Olga Mulas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Mulas. Olga Mulas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa, Alessandro Nanni, et al.. (2025). Beneath the surface in autoimmune hemolytic anemia: pathogenetic networks, therapeutic advancements and open questions. Frontiers in Immunology. 16. 1624667–1624667.
2.
Costa, Alessandro Nanni, Federica Pilo, Matteo Piga, et al.. (2025). VEXAS syndrome: is it more a matter of inflammation or hematopoietic clonality? A case series approach to diagnosis, therapeutic strategies and transplant management. Annals of Hematology. 104(1). 253–262. 2 indexed citations
3.
Costa, Alessandro Nanni, Elisabetta Abruzzese, Roberto Latagliata, et al.. (2024). Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia. Journal of Clinical Medicine. 13(1). 273–273. 3 indexed citations
4.
Bernardi, Simona, et al.. (2024). Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules. Frontiers in Oncology. 13. 1239042–1239042. 6 indexed citations
5.
6.
Mulas, Olga, Fabio Efficace, Maria Grazia Orofino, et al.. (2023). Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation. Journal of Clinical Medicine. 12(18). 6047–6047. 3 indexed citations
7.
Costa, Alessandro Nanni, Giovanni Caocci, Federico Migliore, et al.. (2023). The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia. SHILAP Revista de lepidopterología. 4(3). 207–226. 2 indexed citations
8.
Massa, Elena, Clelia Donisi, Mario Scartozzi, et al.. (2023). Understanding the User's Point of View: When the Doctor Gets Sick with Cancer and Seeks Help. Clinical Practice and Epidemiology in Mental Health. 19(1). 1 indexed citations
9.
Caocci, Giovanni, Olga Mulas, Susanna Barella, et al.. (2023). Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy. Journal of Clinical Medicine. 12(7). 2547–2547. 3 indexed citations
10.
Caocci, Giovanni, Fabio Efficace, Olga Mulas, et al.. (2022). Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomy. Annals of Hematology. 101(4). 749–754. 2 indexed citations
11.
12.
13.
Mulas, Olga, et al.. (2022). Systematic Review and Meta-Analysis of Health-Related Quality of Life in Patients with β-Thalassemia that Underwent Hematopoietic Stem Cell Transplantation. Clinical Practice and Epidemiology in Mental Health. 19(1). e174501792301031–e174501792301031. 2 indexed citations
14.
Morelli, Emanuela, Olga Mulas, & Giovanni Caocci. (2021). Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clinical Practice and Epidemiology in Mental Health. 17(1). 264–270. 6 indexed citations
15.
Giesinger, Johannes M., Giorgio La Nasa, Matthias C. Angermeyer, et al.. (2021). Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials. Clinical Practice and Epidemiology in Mental Health. 17(1). 307–314. 4 indexed citations
16.
Mulas, Olga, et al.. (2021). Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 12. 674748–674748. 9 indexed citations
17.
Sicuranza, Anna, Elisabetta Abruzzese, Alessandra Iurlo, et al.. (2021). Pro-Inflammatory and Pro-Oxidative Changes during Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study). Blood. 138(Supplement 1). 1479–1479.
18.
Caocci, Giovanni, et al.. (2020). Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical setting. International Journal of Hematology. 111(5). 614–618. 6 indexed citations
19.
Caocci, Giovanni, Marianna Greco, Marcella Arras, et al.. (2017). HLA-G molecules and clinical outcome in Chronic Myeloid Leukemia. Leukemia Research. 61. 1–5. 13 indexed citations
20.
Caocci, Giovanni, Bruno Martino, Marianna Greco, et al.. (2015). Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients. Experimental Hematology. 43(12). 1015–1018.e1. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Fogliatto Breakdown of academic impact, for papers by Mariarita Sciumé Breakdown of academic impact, for papers by Vincenzo Federico Breakdown of academic impact, for papers by Adriano Salaroli Breakdown of academic impact, for papers by Anna Lübking Breakdown of academic impact, for papers by Christos Demosthenous Breakdown of academic impact, for papers by Shinichiro Machida Breakdown of academic impact, for papers by Alessandra Cupri Breakdown of academic impact, for papers by Kristina Schilling Breakdown of academic impact, for papers by Caterina Stefanizzi
Rankless by CCL
2026